Introducing SV NAV+

Rely on technology proven to help CLABSI and CRBSI prevention, validated by over 30 peer-reviewed studies and meta-analysis.1-38
Rethink costs by reducing infections and complications – ~$45k to treat one single CRBSI case and ~$16k impact of a single UEDVT.23-28
Minimize platelet aggregation leading to occlusions with disruptive technology that is present throughout the catheter shaft for the life of the catheter.
Reimagine your choices and provide a better patient experience.
*Currently branded and sold as Cook Spectrum® Technology. †Endexo is a registered trademark of Evonik Canada Inc.